T
Trace Genomics
Advanced prevention and management of agricultural diseases
About Trace Genomics
Trace Genomics leverages advanced soil genomics, soil science, and machine learning to provide comprehensive insights into soil biology, physical properties, and chemistry. Serving agronomists, farmers, and agricultural retailers, the company operates in the precision agriculture market. Trace Genomics' business model revolves around offering detailed soil analysis and actionable insights, enabling clients to optimize crop yields and manage soil health effectively. Revenue is generated through subscription-based services and partnerships with agricultural retailers and next-generation product companies. The company stands out by delivering a complete understanding of soil conditions, which helps in making informed decisions for economic and ecosystem benefits.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Ames, United States
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 61.6/100
- Sub-industry
- AgriTech
- Sector
- Food, Farming, Biotechnology, DNA, Genetics and genomics, Core AI, Spinout, Genome Engineering, Sustainable Development Goals, Regenerative Agriculture, Climate Tech, AI Applications, DT and LS, science-based
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Feb 2024 | $11M | $86M | Ajax Investment Strategies · Rabo Ventures · S2G Investments | ↗ |
| SERIES BOther financing | Oct 2022 | $8.1M | $32M | Fall Line Capital · Cavallo Ventures · Stage 1 Ventures · S2G Investments | — |
Growth signals
Latest recorded traffic for Trace Genomics is 110 monthly website visits, down 71.1% over the last three months. Trace Genomics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Refactor Capital
Fall Line Capital
SVG Partners
Viking Global Investors
Series A8 investors entered at this stage
Stage 1 Ventures
Tiger Global
AgFunder
S2G Investments
Trailhead Capital
Cavallo Ventures
Ajax Investment Strategies
Rabo Ventures
Other known investors1 additional known investor
Stanford University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Trace Genomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Trace Genomics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







